Moderna’ Stock Rises 12% as Covid-19 Vaccine Advances to Trial on 30,000 People
Moderna announced on Monday that it had started the first phase III study of a vaccine in the US. The
July 27, 2020
- July 26, 2025
Moderna announced on Monday that it had started the first phase III study of a vaccine in the US. The
By clicking the Subscribe button, you confirm that you have read our Privacy Policy and consent to receive newsletters from us.
We uphold the highest standards of journalistic integrity and ethical reporting, ensuring that truth and transparency prevail in all our content.
Arbiterz profiles Nigerians creating livelihoods and building businesses and analyses the economic and political ideas that shape the opportunities and constraints they encounter.
brandstories@arbiterz.com
+234-1-4489262 | 1-454 8069
7th Floor, Mulliner Towers, 39, Alfred Rewane Road, Ikoyi, Lagos.
brandstories@arbiterz.com
brandstories@arbiterz.com
© Arbiterz 2025, All Rights Reserved. | Powered by ONMATECH.
Get notified about new articles
